Resistant starch (RS) includes the sum of starch and degradation products of starch that resist small intestinal digestion and enter the colon. This study was planned to examine the effect of resistant starch on hypolipidemic actions, blood glucose, insulin levels and humoral immune responses in healthy overweight subjects. Healthy overweight sub jects (over 120% of their ideal body weights) were fed either 24g/d of resistant corn starch (RS) or regular corn starch (CS) for 21d with their regular meals. Although this double blind feeding regiment resulted in no significant changes in their weights or other physical parameters for the relatively acute period of intakes, there were significant lowering effects of serum total cholesterol (p<0.05) and serum LDL-cholesterol (p<0.05) in subjects supple mented RS. Compared with the control starch group, the RS supplementation also reduced the mean fasting serum glucose concentrations (p<0.05). Resistant starch supplement resulted in the increase in serum immunoglobulin G (IgG) concentrations. Serum insulin and complement 3 (C3) were unaffected. Tested resistant starch supplementation was reported to be palatable with minimal bowel discomfort. These results suggest that RS sup plementation improves the blood lipid profile and controls the blood glucose levels in healthy overweight subjects without bowel discomfort, Therefore, RS has a potential to be used as one of the promising food ingredients for reducing risk factors involved in the development of atherosclerosis and type 2 diabetes in overweight individuals. However, in order to prove RS as a novel therapeutic agent of cardiovascular diseases and diabetes, controlled trials with larger sample sizes and longer duration are warranted.
The past several years there has been continued interest in physiological effects of resistant starch, since it might be an attractive source of non-caloric food with a more palatable character than insoluble dietary fiber. The European PLAIR Concerted Action on Resistant Starch (EURESTA) has defined resistant starch (RS) as the sum of starch and products of starch hydrolysis not absorbed in the small intestine of healthy individuals (1, 2) . Even though the importance of resistant starch to human health problems such as obesity, diabetes, ath erosclerosis, and cancer has not been clearly elucidated, its hypolipidemic (3-7) and occasional prebiotic effects (8) (9) (10) (11) were noticed. It is generally accepted that RS replaced for digestible starch in the diet can lower serum cholesterol concentrations in normal or hyper cholesterolemic conditions in animals (3) (4) (5) (6) (7) . However, tying time, and gut hormone profiles (15) (16) (17) . In the small intestine, RS may be slowly absorbed and associ ated with an increased malabsorption of starch which may lead to decreased postprandial glucose and insulin responses (18) . The previous studies on the relationship between the amount of available starch and blood glu cose response has shown a general inverse relationship between blood glucose response and indigestible starch (18) (19) (20) (21) . However, at least two other studies reported that glycemic control was not affected with S in their human subjects (14, 22) . The principle purpose of the present study was to investigate the effect of resistant starch on blood lipid concentrations, and glucose and insulin responses in overweight subjects. The humoral immune parameters (IgG and C3) were also observed in order to examine the effects of RS on immunity, which is often found to be reduced in overnutrition and obesity (23 Subjects were asked to report on a daily basis defeca tion frequency, duration and the degree of bowel dis comfort. The symptoms of nausea, distention and flatulence intensity were comprised of 0-10 scale (0 representing 'absent' and 10 'severe').
Statistical analysis was performed using the Statisti cal Analysis System (SAS, v6.0). Data were expressed as the mean with standard error, and statistically signifi cant differences of the means between two groups were evaluated by Student's t-test and differences of the means between baseline and after supplementation were by paired t-test. 
RESULTS
Anthropometric characteristics of the subjects are presented in Table 2 . There were no significant differ ences in major characteristics between the two experi mental groups. There was no change in body weights after 21 d of the study period. No significant differences were found in nutrient intakes before supplementing 24g of regular corn starch or resistant corn starch containing powder with a regular diet for 21d (Table 3) . Figures 1-4 represent the results of the effect of sup plementing resistant starch on serum triacylglycerols, total cholesterol, LDL-cholesterol and HDL-cholesterol at the baseline and after supplementation. After 21d of supplementation, serum triacylglycerol concentrations of RS group remained unchanged, whereas CS group showed a significant increase. Supplementing RS de creased serum total cholesterol (p<0.05), and LDL-cho Fasting serum glucose levels were significantly de creased after supplementation (Fig. 5) . However, there was no significant influence of resistant starch on serum insulin concentrations (Fig. 6) . (Table  4) .
No significant effects were found with regard to defe cation frequency, defecation time or the degree of bowel complaint at the baseline and after treatment in both of the study groups (Table 5 ).
DISCUSSION
The purpose of the present study was to examine the effects of the consumption of resistant starch in over weight subjects using various parameters related to hypercholesterolemia and glucose control. One of the significant effects of resistant starch is the lowering of serum total cholesterol and LDL-cholesterol concentra tions in this study. In human study, dietary high-amy lose cornstarch compared to low-amylose starch decreased blood cholesterol concentrations by 30-36% (28) . The range of cholesterol lowering was from 8% to 23% in subsequent studies (3) (4) (5) (6) . Triacylglycerol con centration changes were more variable than cholesterol with the range of 0-42% (3-5). The reason why there is no triacylglycerol lowering effect of RS is not clear from this study. But in other studies with hyperlipidemic or normolipidemic subjects, raw or retrograded RS did not without altering its organoleptic properties (5, 36) . Car bohydrates that reach the large intestine provide poten tial energy to colonic microorganisms. Many in vivo studies have shown that RS may be readily fermented by colonic microflora, but differences in fermentability were found (29) . It has been claimed that starch is com pletely fermented by gut bacteria (12) . Further study is needed to clarify the exact colonic process followed by the ingestion of different types of RS. Fasting glucose was significantly higher with control starch supplementation compared to the resistant starch, whereas fasting insulin was unchanged by the two kinds of starch. The differences in fasting glucose response can be attributed from the different energy contents of the supplements. The subjects consumed approximately 24g starch per day in addition to their regular diet. Since body weight alteration was not found with both the control group and the experimen tal group after 21d of supplementation, the subjects may have been compensated through the reduced energy intake of their regular diet, especially for the control group.
The reason for the variations in glycemic control responses that were observed with RS feeding human studies is not clear. The differences in nature of RS, study subjects as well as feeding regiments may be the contributing factors. In fact, the differences in RS have been suggested to play a role in glycemic response (12) , wolf et al. (22) have found no significant glucose lower ing action with RS from corn, whereas wakabayashi et al. (21) have noticed a beneficial glycemic response with RS from potato.
In relation to glucose response, serum insulin con centrations were measured. There were no significant differences in serum insulin concentrations. Some stud ies have observed the improvement of insulin response along with glucose response by feeding RS (18, 19, 21) .
A slight modulation of humoral immunity as measured by IgG levels was noticed.
The habitual pattern of defecation of the study sub jects was not changed with the consumption of RS. No report of physiological bowel discomfort was noted by feeding RS in this study. In summary, it has been shown that resistant starch supplementation at the level of 24g/d with their regu lar diet could lower serum cholesterol and glucose con centrations in overweight subjects. These physiological actions along with favorable palatability without bowel discomfort render resistant starch as an attractive food ingredient for controlling the risk factors of atheroscle rosis and diabetes development.
